Investigation of Galectin-3 and Glucagon-Like Peptide (9-36) Amide Levels in Patients Diagnosed with Benign Prostatic Hyperplasia
which constitutes the predominant circulating form, and GLP-1 (7-37), a less abundant but functionally relevant variant.The inactive degradation products of GLP-1 by dipeptidyl peptidase-4 (DPP-4) are GLP-1 (9-36) amide and GLP-1 (9-37).These metabolites have minimal receptor affinity and are subsequently eliminated through renal clearance mechanisms.GLP-1
Authors
- Erdal Benli̇ (ORCID: https://orcid.org/0000-0001-8485-1424)
- Burcu Yağız (ORCID: https://orcid.org/0000-0002-0624-1986)
- Tevfik Noyan (ORCID: https://orcid.org/0000-0002-7733-0177)
Publication Details
- Journal
- Van Medical Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5505/vmj.2025.35119
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00